Skip to content

Advertisement

You're viewing the new version of our site. Please leave us feedback.

Learn more

Articles from the Drug Safety and Effectiveness Network (DSEN)

A thematic series published in Systematic Reviews.

The Canadian Institute of Health Research (CIHR), along with Health Canada and other stakeholders, established the DSEN to identify gaps in knowledge about drug effectiveness and safety. This series includes a number of articles from the network investigating a range of drugs used in various conditions, including heart disease and diabetes.

  1. Content type: Protocol

    Type 1 diabetes mellitus (T1DM) causes progressive destruction of pancreatic beta cells leading to absolute insulin deficiency. Treatment of T1DM requires insulin, and some evidence suggests that longer acting...

    Authors: Andrea C Tricco, Huda M Ashoor, Charlene Soobiah, Brenda Hemmelgarn, David Moher, Brian Hutton, Catherine H Yu, Sumit R Majumdar and Sharon E Straus

    Citation: Systematic Reviews 2013 2:73

    Published on:

  2. Content type: Protocol

    Hypertension has been cited as the most common attributable risk factor for death worldwide, and in Canada more than one of every five adults had this diagnosis in 2007. In addition to different lifestyle modi...

    Authors: Brian Hutton, Jennifer Tetzlaff, Fatemeh Yazdi, Justin Thielman, Salmaan Kanji, Dean Fergusson, Lise Bjerre, Edward Mills, Kristian Thorlund, Andrea Tricco, Sharon Straus, David Moher and Frans HH Leenen

    Citation: Systematic Reviews 2013 2:44

    Published on:

  3. Content type: Protocol

    Serotonin (5-HT3) receptor antagonists are a class of antiemetic medications often used to prevent nausea and vomiting among patients undergoing chemotherapy, radiotherapy or surgery. However, recent studies s...

    Authors: Andrea C Tricco, Charlene Soobiah, Jesmin Antony, Brenda Hemmelgarn, David Moher, Brian Hutton and Sharon E Straus

    Citation: Systematic Reviews 2013 2:46

    Published on:

  4. Content type: Protocol

    Type 2 diabetes mellitus (T2DM) results from insulin resistance and relative insulin deficiency. T2DM treatment is a step-wise approach beginning with lifestyle modifications (for example, diet, exercise), fol...

    Authors: Andrea C Tricco, Jesmin Antony, Charlene Soobiah, Brenda Hemmelgarn, David Moher, Brian Hutton, Catherine H Yu, Sumit R Majumdar and Sharon E Straus

    Citation: Systematic Reviews 2013 2:47

    Published on:

  5. Content type: Protocol

    Patients undergoing surgery or chemotherapy often experience nausea and vomiting. To increase their quality of life and treatment satisfaction, antiemetic medication, such as serotonin receptor antagonists, is...

    Authors: Andrea C Tricco, Charlene Soobiah, Jesmin Antony, Brenda Hemmelgarn, David Moher, Brian Hutton and Sharon E Straus

    Citation: Systematic Reviews 2013 2:45

    Published on:

Advertisement